pramipexole - PubChem

pramipexole - Compound Summary (CID 59868)
Also known as: Mirapex, Dexpramipexole, Pramipexol, 104632-28-2, STK621530, Pramipexol [Spanish], Pramipexolum [Latin], Pramipexole 2HCl Monohydrate
Molecular Formula: C10H17N3S   Molecular Weight: 211.32708   InChIKey: FASDKYOPVNHBLU-SSDOTTSWSA-N
Pramipexole (INN, trade names Mirapex® and Sifrol®) is a medication indicated for treating Parkinson's disease and restless legs syndrome (RLS). It is also sometimes used off-label as a treatment for cluster headache or to counteract the problems with low libido experienced by some users of SSRI antidepressant drugs. Pramipexole has shown robust effects on pilot studies in bipolar disorder. Pramipexole is classified as a non-ergoline dopamine agonist.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show first sub-section only
Use and Manufacturing
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _